Inclusion body myositis-a case based clinicopathological update

Levente Bodoki, Melinda Vincze, Zoltán Griger, Tamás Csonka, Balázs Murnyák, Andrea Kurucz, K. Dankó, T. Hortobágyi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Inclusion body myositis is a slowly progressive myopathy affecting predominantly the middle-aged and older patient population. It is a major form of the idiopathic inflammatory myopathies which are chronic systemic autoimmune diseases characterized by symmetrical proximal muscle weakness. Unfortunately, there is no effective therapy yet; however, the early diagnosis is essential to provide treatment options which may significantly slow the progression of the disease. In our case-based clinicopathological study the importance of the close collaboration between the clinician and the neuropathologist is emphasised.

Original languageEnglish
Pages (from-to)80-85
Number of pages6
JournalCentral European Journal of Medicine
Volume9
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Inclusion Body Myositis
Myositis
Muscle Weakness
Muscular Diseases
Autoimmune Diseases
Disease Progression
Early Diagnosis
Therapeutics
Population
Neuropathology

Keywords

  • Amyloid
  • Hyperphosphorylated tau
  • Idiopathic inflammatory myopathies
  • Inclusion body myositis (IBM)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Inclusion body myositis-a case based clinicopathological update. / Bodoki, Levente; Vincze, Melinda; Griger, Zoltán; Csonka, Tamás; Murnyák, Balázs; Kurucz, Andrea; Dankó, K.; Hortobágyi, T.

In: Central European Journal of Medicine, Vol. 9, No. 1, 2014, p. 80-85.

Research output: Contribution to journalArticle

Bodoki, Levente ; Vincze, Melinda ; Griger, Zoltán ; Csonka, Tamás ; Murnyák, Balázs ; Kurucz, Andrea ; Dankó, K. ; Hortobágyi, T. / Inclusion body myositis-a case based clinicopathological update. In: Central European Journal of Medicine. 2014 ; Vol. 9, No. 1. pp. 80-85.
@article{1e94d572d4d340ea81185d9c18a269f9,
title = "Inclusion body myositis-a case based clinicopathological update",
abstract = "Inclusion body myositis is a slowly progressive myopathy affecting predominantly the middle-aged and older patient population. It is a major form of the idiopathic inflammatory myopathies which are chronic systemic autoimmune diseases characterized by symmetrical proximal muscle weakness. Unfortunately, there is no effective therapy yet; however, the early diagnosis is essential to provide treatment options which may significantly slow the progression of the disease. In our case-based clinicopathological study the importance of the close collaboration between the clinician and the neuropathologist is emphasised.",
keywords = "Amyloid, Hyperphosphorylated tau, Idiopathic inflammatory myopathies, Inclusion body myositis (IBM)",
author = "Levente Bodoki and Melinda Vincze and Zolt{\'a}n Griger and Tam{\'a}s Csonka and Bal{\'a}zs Murny{\'a}k and Andrea Kurucz and K. Dank{\'o} and T. Hortob{\'a}gyi",
year = "2014",
doi = "10.2478/s11536-013-0250-x",
language = "English",
volume = "9",
pages = "80--85",
journal = "Central European Journal of Medicine",
issn = "1895-1058",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Inclusion body myositis-a case based clinicopathological update

AU - Bodoki, Levente

AU - Vincze, Melinda

AU - Griger, Zoltán

AU - Csonka, Tamás

AU - Murnyák, Balázs

AU - Kurucz, Andrea

AU - Dankó, K.

AU - Hortobágyi, T.

PY - 2014

Y1 - 2014

N2 - Inclusion body myositis is a slowly progressive myopathy affecting predominantly the middle-aged and older patient population. It is a major form of the idiopathic inflammatory myopathies which are chronic systemic autoimmune diseases characterized by symmetrical proximal muscle weakness. Unfortunately, there is no effective therapy yet; however, the early diagnosis is essential to provide treatment options which may significantly slow the progression of the disease. In our case-based clinicopathological study the importance of the close collaboration between the clinician and the neuropathologist is emphasised.

AB - Inclusion body myositis is a slowly progressive myopathy affecting predominantly the middle-aged and older patient population. It is a major form of the idiopathic inflammatory myopathies which are chronic systemic autoimmune diseases characterized by symmetrical proximal muscle weakness. Unfortunately, there is no effective therapy yet; however, the early diagnosis is essential to provide treatment options which may significantly slow the progression of the disease. In our case-based clinicopathological study the importance of the close collaboration between the clinician and the neuropathologist is emphasised.

KW - Amyloid

KW - Hyperphosphorylated tau

KW - Idiopathic inflammatory myopathies

KW - Inclusion body myositis (IBM)

UR - http://www.scopus.com/inward/record.url?scp=84897108718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897108718&partnerID=8YFLogxK

U2 - 10.2478/s11536-013-0250-x

DO - 10.2478/s11536-013-0250-x

M3 - Article

AN - SCOPUS:84897108718

VL - 9

SP - 80

EP - 85

JO - Central European Journal of Medicine

JF - Central European Journal of Medicine

SN - 1895-1058

IS - 1

ER -